Attorney General Ken Paxton secured settlements with WK Kellogg Co. and General Mills Inc. requiring the removal of synthetic dyes from cereals served in schools. The companies have already removed these dyes from K-12 cereals, with full removal from all products by the end of 2027.
The companies agreed to remove synthetic dyes from cereals served in schools by July 1, 2026, and from all products by the end of 2027. Alternative colorings derived from fruit and vegetable juices will be used.
In-house legal teams should review supplier and vendor agreements to ensure compliance with state regulations regarding food ingredients, particularly synthetic dyes. Contracts should include clauses requiring vendors to notify of any ingredient changes and to reformulate products to meet regulatory standards. Additionally, agreements with school food service providers should specify that products served to children must be free from harmful synthetic dyes.
Entity
WK Kellogg Co. and General Mills Inc.
Industry
OtherOfficial Press Release
https://www.texasattorneygeneral.gov/news/releases/major-brands-remove-harmful-dyes-cereals-served-schools-after-signing-historic-settlement-attorney
general mills agrees remove toxic artificial dyes its produc
https://www.texasattorneygeneral.gov/news/releases/general-mills-agrees-remove-toxic-artificial-dyes-its-products-following-investigation-and-legal
attorney general paxton secures historic legal agreement kel
https://www.texasattorneygeneral.gov/news/releases/attorney-general-paxton-secures-historic-legal-agreement-kelloggs-remove-toxic-artificial-dyes-its
Texas Attorney General Enforcement Page
https://www.texasattorneygeneral.gov/consumer-protection/privacy
"WK Kellogg Co. (“Kellogg’s”) and General Mills Inc. (“General Mills”)"
"removed synthetic dyes from their cereal products served in schools"
"committed to permanently removing artificial food colorings from all of its cereal in the United States by the end of 2027"
$3.0M
Texas Attorney General Ken Paxton announced a settlement requiring Temu to protect Texans’ sensitive personal data from exposure to the Chinese Communist Party and to strengthen product-safety practices. Temu must pay Texas $3 million, comply with data-security requirements backed by a potential $8 million annual penalty, conduct annual independent product testing, and take specified action on products found to contain harmful substances.
$773.0M
Texas Attorney General Ken Paxton announced that a multistate coalition had secured an opioid settlement with Albertsons, which would require the grocery chain to pay more than $773 million nationally once final. Texas and its political subdivisions may receive up to $57.8 million for opioid abatement; the release does not identify privacy violations.
Texas Attorney General Ken Paxton sued Gerber Products Company and Nestlé USA, Inc., alleging that Gerber made deceptive safety and testing claims while its baby food contained dangerous levels of toxic heavy metals. The lawsuit asserts claims under the Texas Deceptive Trade Practices Act; the release does not report a settlement, monetary penalty, or court order.
$1.5M
The Texas Attorney General obtained a judgment holding Rubinsky Roofing LLC liable for 27 violations of the Texas Deceptive Trade Practices Act, including deceptive practices involving older consumers and payment for unnecessary or unfinished repairs. The judgment requires more than $1.5 million in civil penalties, allocates at least $500,000 to consumer restitution, and permanently bars the company and its owner from the practices at issue.
The Texas Attorney General opened an investigation into UnitedHealth Group over allegations that its insurance-benefit administration and patient-care decisions denied Texans medically necessary healthcare. The AG issued Civil Investigative Demands to collect evidence; the release announces no penalty or remedy.
$7.5M
Texas Attorney General Ken Paxton announced a $7.5 million settlement with Tris Pharmaceuticals over alleged misrepresentations about the efficacy of Dyanavel XR, an ADHD drug marketed for children. The release says the company overstated the drug’s efficacy and directed sales representatives to make misleading claims to doctors, including Medicaid providers.